Trial intelligence / Profile preview

Botox and Juvederm for Moderate to Severe Facial Wrinkles

NCT01269801Phase 4Completed

Sponsor
AboutSkin Dermatology and DermSurgery
Start
Jan 2011
Primary completion
Sep 2011
Modality
Recombinant Proteins and Enzymes
Countries
2
01

Overview

A Phase 4 trial of botulinum toxin type A, Juvéderm in rhytides, sponsored by AboutSkin Dermatology and DermSurgery. Started Jan 2011; status: completed.

02

Drugs

botulinum toxin type AJuvéderm
03

Conditions

rhytides

Beyond the preview

Go deeper on NCT01269801.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01269801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call